Navigation Links
Talyst Announces New Executive to Its Leadership Team
Date:1/26/2011

BELLEVUE, Wash., Jan. 26, 2011 /PRNewswire/ -- Talyst, Inc., dedicated to engineering safer pharmacies, has appointed Steve Short as Vice President of Sales. With Short's extensive expertise and background in healthcare and technology, he will be a strong strategic lead and addition to the company.

"Steve's solid sales experience will be valuable to Talyst's growth," said Ron Strandin, Executive Vice President. "His strong understanding of all markets will be a great asset to the company."

Short most recently lead the sales team at medDISPENSE, which provides decentralized automated medication dispensing systems for health care facilities nationwide. At the company, he built a team that increased sales and expanded the company into new markets, including long-term care and specialty hospitals. Short also expanded medDISPENSE beyond the U.S. and drove international expansion into Canada, Australia and the Middle East.

He has also worked in the healthcare and technology industry in several roles. His roles include leading the Professional Relations division for the eastern U.S. region at the Psychiatric Institutes of America, recruitment and business development roles at Horizon Health and Charter Medical Corporation, and a top sales lead for Envision Telephony.

Short holds a BA Degree in Corporate Communications with minors in Marketing and Management from the Northern Kentucky University.

About Talyst

Talyst is engineering the safer pharmacy. The company was founded in 2002 to provide automated medication-management systems to acute-care hospital pharmacies. The following year Talyst launched AutoPharm®, the innovative software platform designed to drive a complete suite of medication storage, packaging, refrigeration and barcoding hardware.

As of 2010, Talyst has installed automated systems in more than 500 acute-care hospitals, integrated healthcare companies, long-term care facilities
'/>"/>

SOURCE Talyst
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Catalyst Biosciences Receives Milestone Payment from Pfizer for Progress in Lead Hemostasis Program
2. Catalyst Pharmaceutical Partners to Present at the MoneyShow Conference
3. Catalyst Pharmaceutical Partners Regains Compliance with NASDAQ Minimum Bid Price Rule
4. Catalyst Pharmaceutical Partners to Present at the BioNetwork East 2010 Conference
5. Catalyst Pharmaceutical Partners to Present Today at 2010 Epilepsy Pipeline Update Conference
6. Catalyst Pharmaceutical Partners Selected to Present at Epilepsy Conference Highlighting New and Promising Therapies
7. IDEXX Laboratories Announces Catalyst Dx(R) Placement Total for 2009 and Installed Base of SmartService(TM) Customers
8. Catalyst Pharmaceutical Partners Reports Third Quarter 2009 Financial Results
9. Catalyst Pharmaceutical Partners, Inc. Announces Organizational Changes and Extension of Chief Executives Employment Agreement
10. Catalyst Pharmaceutical Partners, Inc. Announces the Closing of $3.97 Million Registered Direct Offering
11. Sigma-Aldrich(R) Partners With Flow Chemistry Leader ThalesNano to Provide CatCart(R) Catalyst Products for Rapidly Growing Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2014)... 1, 2014   Intarcia Therapeutics, Inc. today ... phase 3 clinical trials for ITCA 650 (exenatide, delivered ... osmotic mini-pump). The first trial, FREEDOM-1, was a placebo-controlled, ... and safety of ITCA 650 in patients with type ... to be significantly superior to placebo for both 40 ...
(Date:10/1/2014)... and NOTTINGHAM, England , Oct. ... CBRX ) today announced that its subsidiary, Molecular Profiles ... Trials platform at the annual CPhI/ICSE Worldwide event in ... to support companies with the rapid development of both ... enabling technologies screening platform, which incorporates the company,s existing ...
(Date:10/1/2014)... Oct. 1, 2014  Varian Medical Systems (NYSE: ... results for the fourth quarter of fiscal year 2014 ... 22, 2014.  The news release will be followed by ... p.m. PT.  The news release and a link to ... company website at: www.varian.com/investor .  To access the ...
Breaking Medicine Technology:Intarcia Announces Two Positive Phase 3 Trials for ITCA 650 in Type 2 Diabetes: FREEDOM-1 and FREEDOM-1 High Baseline (HBL) Study Results 2Intarcia Announces Two Positive Phase 3 Trials for ITCA 650 in Type 2 Diabetes: FREEDOM-1 and FREEDOM-1 High Baseline (HBL) Study Results 3Intarcia Announces Two Positive Phase 3 Trials for ITCA 650 in Type 2 Diabetes: FREEDOM-1 and FREEDOM-1 High Baseline (HBL) Study Results 4Intarcia Announces Two Positive Phase 3 Trials for ITCA 650 in Type 2 Diabetes: FREEDOM-1 and FREEDOM-1 High Baseline (HBL) Study Results 5Columbia Laboratories' UK Subsidiary To Launch New Development Platform At CPHI 2Columbia Laboratories' UK Subsidiary To Launch New Development Platform At CPHI 3Varian Medical Systems Schedules Fourth Quarter FY2014 News Release and Conference Call 2
... FLEX ) is expanding its medical disposables offering ... through a share purchase agreement. Slomedical is a leading ... sets to complex devices for minimally-invasive surgery. This deal ... calendar year, pending required regulatory clearances. , Upon ...
... , CLINTON, N.J., Oct. 21 Ikaria Holdings, Inc. ... Award for Excellence in Business Expansion by the New ... employer association in the United States. Ikaria earned ... revenues, as well as the net creation of new ...
Cached Medicine Technology:Flextronics Announces Expansion of Medical Disposables Offering 2Ikaria Receives Award for Excellence by New Jersey Business & Industry Association 2
(Date:10/2/2014)... 2014 Recently, BambooIndustry.com, a professional company ... collection of bamboo floors . What’s more, the ... of its products at the moment. According to the ... 26 percent off. The promotion will be valid until ... http://www.bambooindustry.com ) are all made by qualified workers. A ...
(Date:10/2/2014)... BamboofloorChina.com is a distinguished bamboo product manufacturer ... appreciation from the global customers in the past few ... more excellent items. All its online workers are professional ... , The company has recently added a new ... Furthermore, the company’s marketing specialist has announced that all ...
(Date:10/2/2014)... Children with autism are more sedentary than those without ... active, a small study suggests. Researchers tested the ... autism and some without. Children with autism averaged 50 ... 70 more minutes each day sitting than those without ... on strength, but had similar body-mass index (a measurement ...
(Date:10/2/2014)... Dennis Thompson HealthDay Reporter ... the District of Columbia now have a total of 500 ... has been infecting children since the summer, U.S. health ... have died in recent weeks, but it,s not clear what ... deaths, officials said. Health officials are also trying to ...
(Date:10/1/2014)... new research study published today in the Journal ... patients older than 50 years with moderate or severe ... , Researchers from the University of Melbourne randomly assigned ... pain to no acupuncture or sham or pretend laser ... with participants and acupuncturists blinded to laser and sham ...
Breaking Medicine News(10 mins):Health News:BambooIndustry.com: Great Bamboo Floors At Discounted Rates 2Health News:High Quality Bamboo Panels Online At BamboofloorChina.com 2Health News:Kids With Autism Tend to Be Less Active, Study Says 2Health News:42 States Reporting Respiratory Virus That Targets Kids 2Health News:42 States Reporting Respiratory Virus That Targets Kids 3Health News:Study finds acupuncture does not improve chronic knee pain 2
... method cuts death risk, study finds , WEDNESDAY, Aug. ... who receive early non-invasive ventilation after a breathing tube ... failure or die, a Spanish study has found. , ... of them had high levels of carbon dioxide in ...
... behind progress, study finds , THURSDAY, Aug. 13 (HealthDay ... younger people, new research shows. , And while cancer ... the United States, topping heart disease, that is because ... cancer. , "Older Americans have only experienced decreased [cancer] ...
... YORK, Aug. 13 The International Longevity Center, with support ... $20,000 grants for caregiver training programs. , , ... Initiative grants are part of the Caregiving Project for ... the Schmieding Center for Senior Health and Education. The initiative ...
... , , BALTIMORE, Aug. ... Maryland, the Black Nurses Association of Baltimore and the Greater ... Health Insurer Code of Conduct from the American Medical Association. ... portion of the state,s racial and ethnic minorities, including African ...
... , THOUSAND OAKS, Calif., Aug. 13 ... data from the submitted Biologic License Applications (BLAs) for denosumab for ... treatment of bone loss in breast and prostate cancer patients undergoing ... Administration,s (FDA) Advisory Committee for Reproductive Health Drugs (ACRHD). , ...
... RICHMOND, Va., Aug. 13 Insmed Inc. (Nasdaq: ... second quarter and six-months ended June 30, 2009. , , ... were $3.0 million, up from $2.7 million for the corresponding period ... grant revenue related to the IPLEX(TM) myotonic muscular dystrophy ("MMD") clinical ...
Cached Medicine News:Health News:Ventilation After Breathing Tube Removal May Alter Outcomes 2Health News:Cancer Deaths Declining, Especially Among Young 2Health News:Cancer Deaths Declining, Especially Among Young 3Health News:Fifteen Community Colleges Win Awards for Innovative Caregiving Training Programs 2Health News:Fifteen Community Colleges Win Awards for Innovative Caregiving Training Programs 3Health News:Fifteen Community Colleges Win Awards for Innovative Caregiving Training Programs 4Health News:Fifteen Community Colleges Win Awards for Innovative Caregiving Training Programs 5Health News:Leading African American Groups Call On Health Insurers to Dismiss Restrictive Practices 2Health News:Leading African American Groups Call On Health Insurers to Dismiss Restrictive Practices 3Health News:Amgen to Discuss Denosumab Data at Today's Advisory Committee for Reproductive Health Drugs 2Health News:Amgen to Discuss Denosumab Data at Today's Advisory Committee for Reproductive Health Drugs 3Health News:Amgen to Discuss Denosumab Data at Today's Advisory Committee for Reproductive Health Drugs 4Health News:Amgen to Discuss Denosumab Data at Today's Advisory Committee for Reproductive Health Drugs 5Health News:Amgen to Discuss Denosumab Data at Today's Advisory Committee for Reproductive Health Drugs 6Health News:Amgen to Discuss Denosumab Data at Today's Advisory Committee for Reproductive Health Drugs 7Health News:Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2009 2Health News:Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2009 3Health News:Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2009 4Health News:Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2009 5Health News:Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2009 6Health News:Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2009 7Health News:Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2009 8Health News:Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2009 9
.90mm (20G) guillotine cutting probe with 1.4mm (17G) removable irrigation sleeve...
Cannula: .90mm x 28mm (20 G x 1 1/8 in) Handle: 9.3cm (3 5/8 in) long, Flute, .90 x 28mm, vacuum handle [Charles]...
...
Designed for stab incisions...
Medicine Products: